Document is current
Any future updates will be listed below
-
Authors
Parenti, Giancarlo https://orcid.org/0000-0002-6287-5748
Medina, Diego L https://orcid.org/0000-0002-7347-2645
Ballabio, Andrea https://orcid.org/0000-0003-1381-4604
-
Funding
Funding for this research was provided by:
Fondazione Telethon (TGM16CB6)
H2020 European Research Council (694282)
National Institutes of Health (R01‐NS078072)
Associazione Italiana per la Ricerca sul Cancro
Associazione Italiana Rett
- License Information
-
More Information
Article History
Received: 28 May 2020
Revised: 9 November 2020
Accepted: 10 November 2020
First Online: 18 January 2021
Conflict of interest
: A. Ballabio is co‐founder of CASMA Therapeutics and of Next Generation Diagnostics (NGD).
